P&SMS Project Overview. An agency of the European Union

Similar documents
SPOR data management services - high level changes

Telematics Governance

SPOR for VETERINARY. EU Network Data Board / SPOR Task Force 29, 30 June 1 July Presented by: Jos Olaerts Veterinary Division

Speed to IDMP Readiness A case study in data mining

Pharmacovigilance: Information systems and services

EudraVigilance Veterinary

Agenda item 4.1 Draft proposal - Notifications of the location of the Pharmacovigilance System Master File (PSMF)

Process and Architecture Overview IDMP Identification of Medicinal Products. Sven Eller, Life Sciences Solution Engagement Manager

New EudraVigilance functionalities and the 2010 pharmacovigilance legislation preparing for change

European Union Network Data Board Terms of Reference

Clinical Trial Safety Reporting requirements

EMA pharmacovigilance system manual

Work plan for the CVMP Pharmacovigilance Working Party (PhVWP-V) 2018

Questions And Answers To Support The

Introduction to the Identification of Medicinal Products ( IDMP)

BULGARIAN ASSOCIATION FOR DRUG INFORMATION (BADI)

Five years as EMA Liaison at US FDA

Update on EMA Brexit preparedness

Initiation Report Inland Revenue Transformation Plan project

EudraVigilance auditable requirement project

Procedure management of variations

Connecting the parts Developing an integrated IDMP strategy

EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update

EMVO FMD Workshop Brussels 13. December 2016

FMD Workshop 27 June 2016

Brexit Guidance for Stakeholders Human and veterinary medicines

Mircea Ciuca, MD Global Head Medical & Clinical Drug Safety

Marketing Authorisation Routes in the EU

Experience of Post approval change management protocol in EU. Mats Welin Senior expert Medical Products Agency Uppsala, Sweden

Data quality control methodology for data submitted under Article 57(2) of Regulation (EC) No.726/2004

EMA action plan related to the European Commission s recommendations on product information 1

Agile solution delivery

Passit4Sure.OG Questions. TOGAF 9 Combined Part 1 and Part 2

The APIC Audit Programme Version 5, July 2017

Fergus Sweeney, European Medicines Agency

EudraCT database and EU Clinical Trials Register (EU-CTR)

The role of the European Commission during the FMD implementation phase Agnès Mathieu DG SANTE European Commission

Medical Literature Monitoring

Note to the competent authority

Brexit info meeting. 5 February 2018

Guideline on good pharmacovigilance practices (GVP)

Regulatory Information Management

CONSULTATION PAPER. Supplementary Standards and Guidance

Institutional Supports and Resources for RIA: The Irish Experience

European Commission s strategy for single market Using Bolar and the SPC Wavier to Stimulate Growth in the EU

Work plan for the GMP/GDP Inspectors Working Group for 2017

Integrity Program Evaluation Using Meaningful Performance Metrics

Revision of the Variations Regulation. Key Principles and Guidelines Development CONTENT

Exploring Communication in the Supply Chain under REACH Authorisation process

DOING NOTHING IS SIMPLY NOT AN OPTION. THE RESULTS OF THE TRAC SERVICES IDMP SURVEY

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

PSMF in Practice Your Questions Answered! GPvP Symposium, 14 March 2014 Jonathan Rowell, Senior GPvP Inspector

Mandate and objectives for the EMA Working Party on Quality Review of Documents (QRD)

17 February 2016 Version 3.0. EU Medicines Agencies Network Strategy to 2020 Heads of Medicines Agencies (HMA) Multi-annual Work Plan

Questions and Answers

EU scientific regulatory support mechanisms and initiatives for innovation in drug development: the EMA perspective

EudraVigilance access policy for medicines for human use

SC6 CALLS in 2018 Europe in a Changing world Inclusive, innovative and reflective societies Helena Vänskä, NCP

Distance sales of medicinal products, the legal framework: EU Directive 2011/62/EU

JOB DESCRIPTION. Community Led Local Development (CLLD) Programme Manager. The four CLLD Local Action Groups across Cornwall (Functional Management)

PEFC contribution to the review. of the EU Timber Regulation

European Regulations for Medicines Place and Role of the EDQM and the European Pharmacopoeia

The Role of Energy Service Companies (ESCOs) in Energy Performance Contracting (EPC) IEE project TRANSPARENSE

Functioning of the PRAC

Audit of Human Resources Planning

European Medicines Agency practical guidance on the application form for centralised type IA and IB variations

#H2020TransportInfo. WP 2017 Call: Automated Road Transport (ART) 3 topics

Di Renzo Regulatory Affairs ROME - MILAN - LONDON

The EU Single Market for Green Products initiative (SMGP)

HEALTHY BEES PLAN IMPLEMENTATION BRIEF

Introductory cover note to the List of European Union reference dates and frequency of submission of Periodic Safety Update Reports

The new Pharmacovigilance legislation and implementation planning

ECHA policy for prevention of conflicts of interest

MS- Customer Feedback Survey. 64th Advisory Forum Meeting, EFSA, 8-9 June 2017

Update on the review of Focal Point Grant Agreements for Sérgio Potier Rodeia Engagement and Cooperation Unit (ENCO)

Draft Contract for implementing the actions Budget Heading Call for proposals VP/2013/001 CALL FOR TENDERS

E2B, Safety databases & Eudravigilance

Reflection paper on risk mitigation measures related to the environmental risk assessment of veterinary medicinal products

The European Commission's Proposal to Re-design Existing European Drug Safety Rules. An Industry View on Practical Implications

Q10 PHARMACEUTICAL QUALITY SYSTEM

EU Rural Networks Strategic Framework and governance bodies

All NEMOs proposal for the price coupling algorithm and for the continuous trading matching algorithm, also incorporating TSO and NEMO proposals for

ONE Order Program Summary

REACHing the 2020 goals

1. Is the proposed definition of modern slavery appropriate and simple to understand?

ABPI response to European Commission consultation on advanced therapy medicinal products

Joint EA - EDQM Communication regarding cooperation when carrying out (joint) audits/assessments in Official Medicines Control Laboratories

EXTERNAL EVALUATION OF THE EUROPEAN UNION AGENCY FOR FUNDAMENTAL RIGHTS DRAFT TECHNICAL SPECIFICATIONS

EBA/CP/2016/ December Consultation Paper. Draft Guidelines on supervision of significant branches

Deliverable 3.2 Overview of existing experiences: case studies on simplification measures adopted

Public-Private Partnerships in Horizon 2020

ACCELERATE YOUR JOURNEY TO BEING DIGITAL

CGMA Competency Framework

Publication of Risk Management Plan (RMP) summaries:

Apprenticeships the impact of trailblazers. Kathryn Porter Divisional Resourcing Director Hilton Worldwide

GUIDANCE FOR IMPLEMENTATION OF THE LEADER COOPERATION ACTIVITIES IN RURAL DEVELOPMENT PROGRAMMES /10/2013.

How to Drive Business Value with Capacity Management

Total Cost of Ownership: Claiming the High Ground

E2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES

Enterprise Architecture and COBIT

Transcription:

P&SMS Project Overview An agency of the European Union

P&SMS Drivers Deliver solutions required by EU law Fulfil regulatory requirements more efficiently Support processes already using SPOR data (backwards compatibility) Implement ISO IDMP standards to support PhV legislation (IDMP compatible) Implement veterinary legislation Deliver integrated SPOR data services Better decisions, faster regulatory action Maintain (or enhance) PhV activities Acting on shortages Establish and improve SPOR data services Provide stakeholder value Increase data quality, simplification of data management practices Improved P&S data management Involvement of NCAs in Product data validation Operational savings and efficiencies Simplification of Type IA variations (+/- 15% reduction in procedures*) Positive impact on public health eprescription Shortages Collaboration with Falsified Medicines hub 1 * According to ROG workplan

P&SMS Risks Risk Impact Mitigation Future solution could become too complex Delayed delivery Scope crunch Focus on minimal viable solution Low NCA engagement Product data not validated by NCAs Benefits not materialised Low Industry engagement No regulatory compliance Benefits not materialised Brexit Increased resource demands from the network to overcome UK loss Project could be slowed/disrupted or even stopped Invest on communication and change management Sell the Business case (prove benefits e.g. process simplification) Escalate in Telematics Invest on communication and change management Sell the Business case (prove benefits e.g. process simplification) Timebox project to 2019 at latest Focus on Products Deliver efficiencies needed to overcome Brexit shortage of resources Support PhVig and Type I A variation simplification Simplify/de-risk S implementation Project de-prioritisation at EMA Project could be slowed/disrupted or even stopped Continue promoting Business case for SPOR 2

What is SPOR delivering with Iteration(s) 1? OUT OF SCOPE Out of scope PILOT Pilot SPOR IN SCOPE (Draft SA!) SPOR in scope (draft solution architecture) EuPhV Message xevprm Message EMA Gateway IDMP Message SPOR UI (CRUD) OSB (Service layer) CRUD SPOR UI Users NEW/EXISTING Consumer Applications Referentials: ISO IDMP 11239 & 11240 Data from EUTCT, xevmpd Support Backwards Compatibility for systems consuming from EUTCT API Organisations: Data from Internal and Telematics systems (EudraGMDP, SAP and SME) Feedback to Internal and Telematics systems (ECD and xevmpd) US 3 US EU EU EXISTING Consumer Applications EXISTING Consumer Applications xevmpd/ Art 57 EudraPharm Vet Subset of S attributes BC REST API (RMS/SMS) EudraGMDP MDM Hub P SPOR API S O R SAP SME ECD xevmpd EMA Data Stewards Products: Data from xevmpd/art 57 and EudraPharm Vet (+/- 60 fields) New data as per ISO 11615 and 11616 to support specific Business Cases (up to +/- 80 fields) Unknown: Software: implementation and maintenance Initial list set up: effort, resources, duration List maintenance: effort, resources (number and skills) Implication: Cannot plan unless Pilot is run Assumed to be out of scope of Iteration 1 Once Pilot is complete planning may impact overall project Support processing of new messaging IDMP compatible/compliant (format TBC) Support Backwards Compatibility to xevmpd/art 57 and EudraPharm Vet Support NCA involvement in data validation Support O related type IA variation simplification Substances: Consolidated data from EUTCT H, EUTCT V, xevmpd, EudraPharm Vet Simple list to support Backwards Compatibility IDMP/ implementation?

SMS & Implementation SW installed and integrated Initial list set up/mapping complete SAB in place EMA committed to implement EMA is fully committed to building a more comprehensive S able to support extensive regulatory and public health use cases EMA must strive for a robust, feasible and pragmatic plan taking into account EMA and Network resource capabilities Implementation Plan GSR implementation has a few unknowns Software: implementation and maintenance Initial list set up: effort, resources, duration List maintenance: effort, resources (number and skills) EMA cannot plan a reliable IDMP/ implementation There needs to be a Pilot to address the unknown and bring further light into IDMP/ implementation in EU Proposal by ROG SMS TOM SAB EU implementation approved by HMA Pilot MEB/EMA/Industry Pilot Clarity on Software, initial List set up and TOM Propose Plan/Resources 4

SMS Iteration 1 Scope In scope: Simple list to support regulatory process across EU network Migrated data from EUTCT Human S, EUTCT Vet S, EV Human, EudraPharm Vet A consolidated Human and vet list Capabilities to Support substance data management creation and updates, change requests, translations, subscriptions/notifications, etc Out of scope subject to Pilot: SPOR integration with Initial mapping/set up of the EU substance list together with NCAs Set up of Target Operating Model with Substance Advisory Board ISO IDMP compliant/compatible* EU-US consolidated list Capability to get updates (deltas) from external source (e.g. ) * if updates available the list will be ISO IDMP compatible as IDs/records will be uniquely generates according to ISO 11238 specifications 5

PMS & Suppport to network priorities EMA committed to support network priorities EMA is fully committed to: collect (new) data on products including manufacturers; engage with NCAs in product data validation (PMS TOM) and support the simplification of Type IA variations through data submissions. PMS Implementation Plan PMS implementation in the network has a few unknowns Data collection: What data? Where from? Data validation: How? Against what? For how long? Resources (skills/numbers)? Type IA simplification: Dependencies? When? How? EMA also recommends a Pilot to understand the implications to Industry and NCAs ROG: Type I A simplification SPOR: PMS TOM PMS TOM & ROG BC approved by HMA PMS Pilot EMA/NCAs/Industry Pilot Clarity on data collection and data validation: process, resources Propose Plan/Resources 6

PMS Iteration 1 Scope In scope: Migration data from Art57 and EudraPharm Vet Inclusion of the new data fields agreed in scope for PMS iteration 1 Deliver EU Implementation Guide Out of scope subject to Pilot: Integration with CESSP (to feed PMS in a single step) Art57 business processes and functionality revised in line with the new technology, new data fields, new message(s), additional variation types ( O type 1A variations) Support processing of new messaging ISOIDMP compatible (format TBC) Capabilities to support product data management and data quality assurance & control framework(s) Capability to receive and manage updates from NCAs in the context of the data quality control framework 7

P&SMS Project Timeframes EMA Project activities Manufacturers data collection Manufacturers data validation Type IA Enforcement? 2017 2018 2019 Preliminary BC Analysis and Design Implementation Transition P&SMS Implementation Guides (IGs) P&SMS It1 Go-live Art 57 Enforcement Stages/milestones are indicative and reflect an estimated timeboxed plan based on external drivers/constraints. It requires adjustment of scope vs time so further details will be communicated at a later stage. 8

Telematics Governance involvement 2017 Engagement at Operational level (P&S SG, SPOR TF and Change Liaisons) to ensure requirements are captured and will be met Raise awareness mostly at Tactical level (EUNDB, IT Directors, IT DEC) of: SPOR Business case NCA activities and R&O mapping P&SM plans & approach Support ROG Work Plan 2018 Approvals at Strategic level (EUTMB/HMA) of: P: EU IG (including fields, business process and NCA involvement in data validation) S: Pilot results, EU IG (including fields, business process and NCA (SAB) involvement in data maintenance) Mobilisation of resources at Tactical level (IT Directors) 9

Thank you! 10